<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Juvenile Idiopathic Arthritis - Interactive Algorithm</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
            padding: 20px;
            line-height: 1.6;
        }

        .container {
            max-width: 1400px;
            margin: 0 auto;
            display: flex;
            gap: 30px;
        }

        .main-content {
            flex: 1;
        }

        .header {
            text-align: center;
            margin-bottom: 40px;
            background: white;
            padding: 30px;
            border-radius: 15px;
            box-shadow: 0 10px 30px rgba(0,0,0,0.1);
        }

        .header h1 {
            color: #2c3e50;
            font-size: 2.5em;
            margin-bottom: 10px;
        }

        .header p {
            color: #7f8c8d;
            font-size: 1.1em;
        }

        .card {
            background: white;
            border-radius: 15px;
            margin-bottom: 25px;
            box-shadow: 0 5px 20px rgba(0,0,0,0.1);
            overflow: hidden;
            transition: all 0.3s ease;
        }

        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 10px 30px rgba(0,0,0,0.15);
        }

        .card-header {
            padding: 25px;
            cursor: pointer;
            display: flex;
            align-items: center;
            justify-content: space-between;
            transition: all 0.3s ease;
        }

        .card-header.assessment {
            background: linear-gradient(135deg, #3498db, #2980b9);
            color: white;
        }

        .card-header.diagnosis {
            background: linear-gradient(135deg, #f1c40f, #f39c12);
            color: white;
        }

        .card-header.treatment {
            background: linear-gradient(135deg, #e74c3c, #c0392b);
            color: white;
        }

        .card-header.followup {
            background: linear-gradient(135deg, #27ae60, #2ecc71);
            color: white;
        }

        .card-header:hover {
            filter: brightness(1.1);
        }

        .card-title {
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .card-icon {
            font-size: 2em;
            width: 50px;
            height: 50px;
            display: flex;
            align-items: center;
            justify-content: center;
            background: rgba(255,255,255,0.2);
            border-radius: 50%;
        }

        .card-title h2 {
            font-size: 1.5em;
            font-weight: 600;
        }

        .expand-icon {
            font-size: 1.5em;
            transition: transform 0.3s ease;
        }

        .expand-icon.expanded {
            transform: rotate(180deg);
        }

        .card-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease;
        }

        .card-content.expanded {
            max-height: 2000px;
        }

        .card-body {
            padding: 30px;
        }

        .subsection {
            margin-bottom: 25px;
            padding-bottom: 20px;
            border-bottom: 1px solid #ecf0f1;
        }

        .subsection:last-child {
            border-bottom: none;
        }

        .subsection h3 {
            color: #2c3e50;
            margin-bottom: 15px;
            font-size: 1.3em;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .subsection h3::before {
            content: "‚ñ∏";
            color: #3498db;
            font-weight: bold;
        }

        .info-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
            margin: 20px 0;
        }

        .info-card {
            background: #f8f9fa;
            padding: 20px;
            border-radius: 10px;
            border-left: 4px solid #3498db;
        }

        .info-card h4 {
            color: #2c3e50;
            margin-bottom: 10px;
            font-size: 1.1em;
        }

        .info-card ul {
            list-style-type: none;
        }

        .info-card li {
            padding: 5px 0;
            color: #34495e;
        }

        .info-card li::before {
            content: "‚Ä¢";
            color: #3498db;
            font-weight: bold;
            display: inline-block;
            width: 1em;
            margin-left: -1em;
        }

        .severity-badge {
            display: inline-block;
            padding: 5px 12px;
            border-radius: 20px;
            font-size: 0.85em;
            font-weight: 600;
            text-transform: uppercase;
            margin: 5px;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
        }

        .badge-urgent {
            background: linear-gradient(135deg, #e74c3c, #c0392b);
            color: white;
        }

        .badge-caution {
            background: linear-gradient(135deg, #f39c12, #d35400);
            color: white;
        }

        .badge-stable {
            background: linear-gradient(135deg, #27ae60, #16a085);
            color: white;
        }

        .treatment-algorithm {
            background: #f8f9fa;
            padding: 20px;
            border-radius: 10px;
            margin: 20px 0;
        }

        .treatment-step {
            display: flex;
            align-items: center;
            padding: 15px;
            margin: 10px 0;
            background: white;
            border-radius: 8px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
        }

        .step-number {
            background: #3498db;
            color: white;
            width: 30px;
            height: 30px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: bold;
            margin-right: 15px;
        }

        .sidebar {
            width: 280px;
            position: sticky;
            top: 20px;
            height: fit-content;
        }

        .progress-card {
            background: white;
            border-radius: 15px;
            padding: 25px;
            box-shadow: 0 5px 20px rgba(0,0,0,0.1);
        }

        .progress-card h3 {
            color: #2c3e50;
            margin-bottom: 20px;
            font-size: 1.3em;
        }

        .progress-item {
            display: flex;
            align-items: center;
            padding: 12px;
            margin: 8px 0;
            border-radius: 8px;
            cursor: pointer;
            transition: all 0.3s ease;
            position: relative;
        }

        .progress-item::before {
            content: "";
            position: absolute;
            left: 25px;
            top: -8px;
            bottom: -8px;
            width: 2px;
            background: #ecf0f1;
            z-index: 1;
        }

        .progress-item:first-child::before {
            top: 50%;
        }

        .progress-item:last-child::before {
            bottom: 50%;
        }

        .progress-item.active::before {
            background: #3498db;
        }

        .progress-dot {
            width: 16px;
            height: 16px;
            border-radius: 50%;
            background: #ecf0f1;
            margin-right: 15px;
            position: relative;
            z-index: 2;
            transition: all 0.3s ease;
        }

        .progress-item.active .progress-dot {
            background: #3498db;
            transform: scale(1.3);
        }

        .progress-item.completed .progress-dot {
            background: #27ae60;
        }

        .progress-text {
            color: #7f8c8d;
            font-size: 0.9em;
        }

        .progress-item.active .progress-text,
        .progress-item.completed .progress-text {
            color: #2c3e50;
            font-weight: 600;
        }

        .drug-card {
            background: white;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 15px;
            margin: 10px 0;
        }

        .drug-name {
            font-weight: 600;
            color: #2c3e50;
            margin-bottom: 5px;
        }

        .drug-dose {
            color: #7f8c8d;
            font-size: 0.9em;
        }

        .alert-box {
            background: #fff3cd;
            border: 1px solid #ffeaa7;
            border-radius: 8px;
            padding: 15px;
            margin: 15px 0;
        }

        .alert-box.urgent {
            background: #f8d7da;
            border-color: #f5c6cb;
        }

        .alert-box.stable {
            background: #d4edda;
            border-color: #c3e6cb;
        }

        @media (max-width: 1024px) {
            .container {
                flex-direction: column;
            }
            
            .sidebar {
                width: 100%;
                position: relative;
                top: 0;
            }
        }

        .fade-in {
            animation: fadeIn 0.5s ease-in;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="main-content">
            <div class="header">
                <h1>ü©∫ Juvenile Idiopathic Arthritis</h1>
                <p>Interactive Clinical Decision Support Algorithm | BMJ Best Practice Guidelines</p>
            </div>

            <!-- Assessment Card -->
            <div class="card" id="assessment-card">
                <div class="card-header assessment" onclick="toggleCard('assessment')">
                    <div class="card-title">
                        <div class="card-icon">üìã</div>
                        <h2>Assessment & History</h2>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content" id="assessment-content">
                    <div class="card-body">
                        <div class="subsection">
                            <h3>Key Diagnostic Factors</h3>
                            <div class="info-grid">
                                <div class="info-card">
                                    <h4>Essential Criteria</h4>
                                    <ul>
                                        <li>Age at onset < 16 years</li>
                                        <li>Arthritis duration ‚â• 6 weeks</li>
                                        <li>Objective arthritis in ‚â• 1 joints</li>
                                    </ul>
                                </div>
                                <div class="info-card">
                                    <h4>Common Presentations</h4>
                                    <ul>
                                        <li>Joint pain and swelling</li>
                                        <li>Morning stiffness</li>
                                        <li>Limp or gait abnormality</li>
                                        <li>Limited range of motion</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Detailed History Checklist</h3>
                            <div class="alert-box">
                                <strong>Critical Questions to Ask:</strong>
                                <ul style="margin-top: 10px;">
                                    <li>‚Ä¢ Current joint symptoms (pain, swelling, stiffness)</li>
                                    <li>‚Ä¢ Symmetry of joint involvement</li>
                                    <li>‚Ä¢ Diurnal variation in symptoms</li>
                                    <li>‚Ä¢ Presence of fever or rash</li>
                                    <li>‚Ä¢ Ocular symptoms (uveitis risk)</li>
                                    <li>‚Ä¢ Family history of autoimmunity</li>
                                </ul>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Physical Examination</h3>
                            <div class="info-grid">
                                <div class="info-card">
                                    <h4>Joint Assessment</h4>
                                    <ul>
                                        <li>Swelling/effusion</li>
                                        <li>Increased warmth</li>
                                        <li>Painful limited movement</li>
                                        <li>Tenderness on palpation</li>
                                    </ul>
                                </div>
                                <div class="info-card">
                                    <h4>Systemic Signs</h4>
                                    <ul>
                                        <li>Pyrexia</li>
                                        <li>Macular rashes</li>
                                        <li>Psoriatic scales</li>
                                        <li>Nail changes/dactylitis</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Risk Factors</h3>
                            <span class="severity-badge badge-urgent">Female Sex (3-6.6x higher risk)</span>
                            <span class="severity-badge badge-urgent">HLA Polymorphisms</span>
                            <span class="severity-badge badge-caution">Family History of Autoimmunity</span>
                            <span class="severity-badge badge-caution">Antibiotic Exposure in Childhood</span>
                            <span class="severity-badge badge-caution">Maternal Smoking During Pregnancy</span>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Diagnosis Card -->
            <div class="card" id="diagnosis-card">
                <div class="card-header diagnosis" onclick="toggleCard('diagnosis')">
                    <div class="card-title">
                        <div class="card-icon">üîç</div>
                        <h2>Diagnosis & Classification</h2>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content" id="diagnosis-content">
                    <div class="card-body">
                        <div class="subsection">
                            <h3>ILAR Classification Criteria</h3>
                            <p>Diagnosis requires age at onset < 16 years, disease duration ‚â• 6 weeks, and exclusion of other known conditions.</p>
                        </div>

                        <div class="subsection">
                            <h3>Subtypes Classification</h3>
                            <div class="info-grid">
                                <div class="info-card">
                                    <h4>1. Systemic Arthritis</h4>
                                    <ul>
                                        <li>Daily high-spiking fevers ‚â• 2 weeks</li>
                                        <li>Arthritis in ‚â• 1 joints</li>
                                        <li>Evanescent rash, lymphadenopathy, serositis</li>
                                    </ul>
                                    <span class="severity-badge badge-urgent">10-20% of JIA cases</span>
                                </div>
                                <div class="info-card">
                                    <h4>2. Oligoarthritis</h4>
                                    <ul>
                                        <li>1-4 joints affected in first 6 months</li>
                                        <li>Persistent: ‚â§ 4 joints throughout</li>
                                        <li>Extended: > 4 joints after 6 months</li>
                                    </ul>
                                    <span class="severity-badge badge-caution">50-60% of cases</span>
                                </div>
                                <div class="info-card">
                                    <h4>3. Polyarthritis (RF-negative)</h4>
                                    <ul>
                                        <li>‚â• 5 joints affected</li>
                                        <li>RF-negative tests</li>
                                        <li>Typically young girls</li>
                                    </ul>
                                    <span class="severity-badge badge-caution">30% of cases</span>
                                </div>
                                <div class="info-card">
                                    <h4>4. Polyarthritis (RF-positive)</h4>
                                    <ul>
                                        <li>‚â• 5 joints affected</li>
                                        <li>RF-positive on ‚â• 2 tests</li>
                                        <li>Phenotypically similar to adult RA</li>
                                    </ul>
                                    <span class="severity-badge badge-urgent">2-7% of JIA cases</span>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Laboratory Investigations</h3>
                            <div class="treatment-algorithm">
                                <div class="treatment-step">
                                    <div class="step-number">1</div>
                                    <div>
                                        <strong>First-line Tests:</strong> FBC, ESR, CRP, ANA, RF
                                    </div>
                                </div>
                                <div class="treatment-step">
                                    <div class="step-number">2</div>
                                    <div>
                                        <strong>Consider:</strong> Anti-CCP, Chlamydia screen, Ferritin (if systemic JIA suspected)
                                    </div>
                                </div>
                                <div class="treatment-step">
                                    <div class="step-number">3</div>
                                    <div>
                                        <strong>Imaging:</strong> Ultrasound (early detection), MRI (difficult joints, treatment monitoring)
                                    </div>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Differential Diagnosis</h3>
                            <span class="severity-badge badge-urgent">Septic Arthritis</span>
                            <span class="severity-badge badge-urgent">Malignancy</span>
                            <span class="severity-badge badge-caution">Reactive Arthritis</span>
                            <span class="severity-badge badge-caution">Acute Rheumatic Fever</span>
                            <span class="severity-badge badge-caution">SLE</span>
                            <span class="severity-badge badge-caution">Kawasaki Disease</span>
                        </div>

                        <div class="subsection">
                            <h3>Uveitis Risk Stratification</h3>
                            <div class="alert-box urgent">
                                <strong>High Risk Features:</strong> Oligoarticular JIA, RF-negative polyarticular JIA, ANA positivity, age < 7 years at onset, disease duration ‚â§ 4 years
                            </div>
                            <div class="alert-box stable">
                                <strong>Screening:</strong> Every 3 months for high-risk, every 6-12 months for low-risk
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Treatment Card -->
            <div class="card" id="treatment-card">
                <div class="card-header treatment" onclick="toggleCard('treatment')">
                    <div class="card-title">
                        <div class="card-icon">üíä</div>
                        <h2>Treatment & Management</h2>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content" id="treatment-content">
                    <div class="card-body">
                        <div class="subsection">
                            <h3>Treatment Principles</h3>
                            <div class="alert-box stable">
                                <strong>Goals:</strong> Achieve clinically inactive disease, prevent joint damage, minimize treatment side effects, promote physical and mental well-being
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Polyarticular JIA (‚â•5 joints)</h3>
                            <div class="treatment-algorithm">
                                <h4>First-line Treatment</h4>
                                <div class="drug-card">
                                    <div class="drug-name">Methotrexate</div>
                                    <div class="drug-dose">10-15 mg/m¬≤/week (max 25mg/week)</div>
                                    <span class="severity-badge badge-stable">First-line DMARD</span>
                                </div>
                                
                                <h4 style="margin-top: 20px;">Biological Agents (add-on or for poor prognosis)</h4>
                                <div class="info-grid">
                                    <div class="drug-card">
                                        <div class="drug-name">Adalimumab</div>
                                        <div class="drug-dose">Every 2 weeks SC</div>
                                        <span class="severity-badge badge-caution">TNF-Œ± inhibitor</span>
                                    </div>
                                    <div class="drug-card">
                                        <div class="drug-name">Etanercept</div>
                                        <div class="drug-dose">Weekly SC</div>
                                        <span class="severity-badge badge-caution">TNF-Œ± inhibitor</span>
                                    </div>
                                    <div class="drug-card">
                                        <div class="drug-name">Tocilizumab</div>
                                        <div class="drug-dose">IV every 2-4 weeks or SC weekly</div>
                                        <span class="severity-badge badge-caution">IL-6 inhibitor</span>
                                    </div>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Oligoarticular JIA (‚â§4 joints)</h3>
                            <div class="treatment-algorithm">
                                <div class="treatment-step">
                                    <div class="step-number">1</div>
                                    <div>
                                        <strong>Intra-articular Corticosteroids:</strong> First-line for most patients
                                    </div>
                                </div>
                                <div class="treatment-step">
                                    <div class="step-number">2</div>
                                    <div>
                                        <strong>NSAID Monotherapy:</strong> 2-month trial if low disease activity, no contractures, no poor prognostic features
                                    </div>
                                </div>
                                <div class="treatment-step">
                                    <div class="step-number">3</div>
                                    <div>
                                        <strong>Methotrexate:</strong> If no response to corticosteroids or high disease activity with poor prognostic features
                                    </div>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Systemic-onset JIA</h3>
                            <div class="alert-box urgent">
                                <strong>Macropahge Activation Syndrome (MAS) Risk:</strong> Life-threatening complication in 10-15% of patients
                            </div>
                            <div class="treatment-algorithm">
                                <h4>Without MAS</h4>
                                <div class="drug-card">
                                    <div class="drug-name">IL-1 inhibitors (Anakinra, Canakinumab)</div>
                                    <div class="drug-dose">First-line biological agents</div>
                                    <span class="severity-badge badge-stable">High efficacy</span>
                                </div>
                                <div class="drug-card">
                                    <div class="drug-name">IL-6 inhibitors (Tocilizumab)</div>
                                    <div class="drug-dose">Alternative first-line option</div>
                                    <span class="severity-badge badge-stable">High efficacy</span>
                                </div>
                                
                                <h4 style="margin-top: 20px;">With MAS</h4>
                                <div class="alert-box urgent">
                                    <strong>Urgent Treatment:</strong> Biological agents + high-dose systemic corticosteroids. Consult pediatric rheumatology immediately
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Supportive Care</h3>
                            <div class="info-grid">
                                <div class="info-card">
                                    <h4>Physical Therapy</h4>
                                    <ul>
                                        <li>Range of motion exercises</li>
                                        <li>Weight-bearing activities</li>
                                        <li>Foot orthoses if needed</li>
                                    </ul>
                                </div>
                                <div class="info-card">
                                    <h4>Psychological Support</h4>
                                    <ul>
                                        <li>Psychiatric morbidity screening</li>
                                        <li>Family support strategies</li>
                                        <li>Treatment adherence counseling</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Follow-up Card -->
            <div class="card" id="followup-card">
                <div class="card-header followup" onclick="toggleCard('followup')">
                    <div class="card-title">
                        <div class="card-icon">üìä</div>
                        <h2>Follow-up & Monitoring</h2>
                    </div>
                    <div class="expand-icon">‚ñº</div>
                </div>
                <div class="card-content" id="followup-content">
                    <div class="card-body">
                        <div class="subsection">
                            <h3>Monitoring Schedule</h3>
                            <div class="treatment-algorithm">
                                <div class="treatment-step">
                                    <div class="step-number">1</div>
                                    <div>
                                        <strong>Laboratory Monitoring:</strong> FBC, LFTs, renal function every 3-4 months during treatment
                                    </div>
                                </div>
                                <div class="treatment-step">
                                    <div class="step-number">2</div>
                                    <div>
                                        <strong>Ophthalmologic Screening:</strong> Every 3 months (high-risk) or 6-12 months (low-risk)
                                    </div>
                                </div>
                                <div class="treatment-step">
                                    <div class="step-number">3</div>
                                    <div>
                                        <strong>Disease Activity:</strong> Assess joints, inflammatory markers, patient/physician global scores
                                    </div>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Complications to Monitor</h3>
                            <div class="info-grid">
                                <div class="info-card">
                                    <h4>Joint Complications</h4>
                                    <ul>
                                        <li>Joint erosions</li>
                                        <li>Leg length discrepancy</li>
                                        <li>C-spine fusion/C1-C2 subluxation</li>
                                        <li>TMJ involvement</li>
                                    </ul>
                                </div>
                                <div class="info-card">
                                    <h4>Extra-articular</h4>
                                    <ul>
                                        <li>Uveitis (10-20% risk)</li>
                                        <li>Macrophage activation syndrome</li>
                                        <li>Growth disturbances</li>
                                        <li>Osteoporosis</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Treatment Tapering</h3>
                            <div class="alert-box stable">
                                <strong>When to Consider Tapering:</strong> When disease is clinically inactive for at least 6-12 months
                            </div>
                            <div class="alert-box caution">
                                <strong>Tapering Sequence:</strong> Corticosteroids first, then biological agents, then DMARDs. Always under specialist supervision.
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Prognosis</h3>
                            <div class="info-grid">
                                <div class="info-card">
                                    <h4>Good Prognosis Factors</h4>
                                    <ul>
                                        <li>Shorter disease duration before treatment</li>
                                        <li>Good initial response to therapy</li>
                                        <li>Oligoarticular subtype</li>
                                        <li>Early aggressive treatment</li>
                                    </ul>
                                    <span class="severity-badge badge-stable">2/3 achieve remission</span>
                                </div>
                                <div class="info-card">
                                    <h4>Poor Prognosis Factors</h4>
                                    <ul>
                                        <li>RF-positive polyarticular subtype</li>
                                        <li>Systemic-onset subtype</li>
                                        <li>High disease activity at baseline</li>
                                        <li>Joint damage at presentation</li>
                                    </ul>
                                    <span class="severity-badge badge-urgent">May have moderate-severe disability</span>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Vaccination Guidelines</h3>
                            <div class="alert-box caution">
                                <strong>Live vaccines are contraindicated</strong> during immunosuppressive therapy. Annual influenza vaccination recommended for all patients.
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Sidebar -->
        <div class="sidebar">
            <div class="progress-card">
                <h3>üìç Progress</h3>
                <div class="progress-item active" onclick="scrollToCard('assessment')">
                    <div class="progress-dot"></div>
                    <div class="progress-text">Assessment & History</div>
                </div>
                <div class="progress-item" onclick="scrollToCard('diagnosis')">
                    <div class="progress-dot"></div>
                    <div class="progress-text">Diagnosis & Classification</div>
                </div>
                <div class="progress-item" onclick="scrollToCard('treatment')">
                    <div class="progress-dot"></div>
                    <div class="progress-text">Treatment & Management</div>
                </div>
                <div class="progress-item" onclick="scrollToCard('followup')">
                    <div class="progress-dot"></div>
                    <div class="progress-text">Follow-up & Monitoring</div>
                </div>
            </div>
        </div>
    </div>

    <script>
        // Toggle card expansion
        function toggleCard(cardId) {
            const content = document.getElementById(cardId + '-content');
            const icon = document.querySelector(`#${cardId}-card .expand-icon`);
            
            if (content.classList.contains('expanded')) {
                content.classList.remove('expanded');
                icon.classList.remove('expanded');
            } else {
                content.classList.add('expanded');
                icon.classList.add('expanded');
            }
            
            // Smooth scroll to card
            document.getElementById(cardId + '-card').scrollIntoView({
                behavior: 'smooth',
                block: 'start'
            });
        }

        // Scroll to specific card
        function scrollToCard(cardId) {
            const card = document.getElementById(cardId + '-card');
            card.scrollIntoView({
                behavior: 'smooth',
                block: 'start'
            });
            
            // Auto-expand the card
            const content = document.getElementById(cardId + '-content');
            const icon = document.querySelector(`#${cardId}-card .expand-icon`);
            content.classList.add('expanded');
            icon.classList.add('expanded');
        }

        // Update progress sidebar based on scroll position
        function updateProgress() {
            const cards = ['assessment', 'diagnosis', 'treatment', 'followup'];
            const scrollPosition = window.scrollY + 200;
            
            cards.forEach((cardId, index) => {
                const card = document.getElementById(cardId + '-card');
                const progressItem = document.querySelectorAll('.progress-item')[index];
                
                if (card) {
                    const cardTop = card.offsetTop;
                    const cardBottom = cardTop + card.offsetHeight;
                    
                    if (scrollPosition >= cardTop && scrollPosition < cardBottom) {
                        progressItem.classList.add('active');
                        progressItem.classList.remove('completed');
                    } else if (scrollPosition > cardBottom) {
                        progressItem.classList.add('completed');
                        progressItem.classList.remove('active');
                    } else {
                        progressItem.classList.remove('active', 'completed');
                    }
                }
            });
        }

        // Add smooth scrolling and fade-in effects
        document.addEventListener('DOMContentLoaded', function() {
            // Initial animation
            document.querySelectorAll('.card').forEach((card, index) => {
                card.style.opacity = '0';
                card.style.transform = 'translateY(30px)';
                setTimeout(() => {
                    card.style.transition = 'all 0.5s ease';
                    card.style.opacity = '1';
                    card.style.transform = 'translateY(0)';
                }, index * 100);
            });

            // Scroll event listener
            window.addEventListener('scroll', updateProgress);
            
            // Add hover effects to cards
            document.querySelectorAll('.card').forEach(card => {
                card.addEventListener('mouseenter', function() {
                    this.style.transform = 'translateY(-5px)';
                    this.style.boxShadow = '0 10px 30px rgba(0,0,0,0.15)';
                });
                
                card.addEventListener('mouseleave', function() {
                    this.style.transform = 'translateY(0)';
                    this.style.boxShadow = '0 5px 20px rgba(0,0,0,0.1)';
                });
            });
        });

        // Add click effects to severity badges
        document.querySelectorAll('.severity-badge').forEach(badge => {
            badge.addEventListener('click', function() {
                this.style.transform = 'scale(0.95)';
                setTimeout(() => {
                    this.style.transform = 'scale(1)';
                }, 100);
            });
        });

        // Add smooth transitions to info cards
        document.querySelectorAll('.info-card').forEach(card => {
            card.addEventListener('mouseenter', function() {
                this.style.transform = 'scale(1.02)';
                this.style.boxShadow = '0 5px 15px rgba(0,0,0,0.1)';
            });
            
            card.addEventListener('mouseleave', function() {
                this.style.transform = 'scale(1)';
                this.style.boxShadow = 'none';
            });
        });
    </script>
</body>
</html>